𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of bombesin on human small cell lung cancer cells: Evidence for a subset of bombesin non-responsive cell lines

✍ Scribed by Helen Kado-Fong; Bernard Malfroy


Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
492 KB
Volume
40
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


The effects of bombesin on three human small cell lung carcinoma cell (SCLC) lines (NCI-H69, NCI-H128, and NCI-H345) have been examined and compared to the effects of the peptide on the mouse fibroblast cell line Swiss 3T3, and the rat pituitary tumor cell line GH3W5. While all three SCLC lines expressed messenger RNA encoding pregastrin releasing peptide (GRP), only the NCI-H345 cells expressed detectable membrane receptors for GRP and responded to nanomolar mncentrations of bombesin as shown by '%GRP binding, total inositol phosphate accumulation, and increased clonal growth in soft agarose. These data show that some SCLC lines are insensitive to bombesi and do not express detectable membrane receptors for GRP.

Key wonk growth factor, gastrin rekasiq peptide, GRP receptor, inositd phospbste, clonal growth Bombesin, a tetradecapeptide isolated from frog skin [ 13, exhibits a wide array of biological activities [2]. In particular, it displays mitogenic properties on mouse fibre blasts and human bronchial epithelial cells in vitro [3,4]. This effect of bombesin on fibroblasts is thought to involve binding of bombesin to high-affinity membrane receptors followed by an increase in intracellular phosphatidylinositol (PI) turnover [ 5,6]. Mammalian counterparts of bombesin have been identified and characterized. These bombinlike peptides, fragments of a 27-amineacid-long peptide, gastrin-releasing peptide (GRP), all share with bombesin the same carboxy terminal heptapeptide. This carboxy terminal portion has been shown to be necessary for biological activity of GRP [7-91. Peptides from the GRP family are produced in human small cell lung cancer (SCLC) cells [1&12]. These peptides have been shown to have mitogenic effects on some SCLC cells in culture [13-151. Furthermore, monoclonal antibodies against the carboxy terminus of GRP were found to inhibit the in vitro growth of SCLC cells in culture, and to reduce tumor growth in nude mice implanted with SCLC cells [ 151. From these data, it has been suggested that bombesin-like peptides from the GRP family


πŸ“œ SIMILAR VOLUMES


Evidence for a role of FGF-2 and FGF rec
✍ Walter Berger; Ulrike Setinek; Thomas Mohr; Ingela Kindas-MΓΌgge; Monika Vetterle πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 375 KB πŸ‘ 2 views

Basic fibroblast growth factor (FGF-2) has been implicated in the progression of human tumours via both autocrine and paracrine (angiogenic) activities. We investigated the expression of FGF-2 and FGF receptors (FGFR-1 to -4) in NSCLC cell lines (N ‫؍‬ 16), NSCLC surgical specimens (N ‫؍‬ 21) and 2

CD80 expression in an HLA-A2-positive hu
✍ Dale L. Bixby; John R. Yannelli πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 185 KB πŸ‘ 2 views

To generate non-small cell lung cancer (NSCLC)-reactive lymphocytes, we transfected an HLA-A2-expressing human NSCLC line (1355) with the cDNA encoding the lymphocyte co-stimulatory molecule CD80. Following selection in G418, 1355.7 demonstrated stable cell-surface expression of CD80. Allogeneic mix

Evaluation of synergism by a novel three
✍ Fumihiko Kanzawa; Kazuto Nishio; Kazuya Fukuoka; Minoru Fukuda; Takehiko Kunimot πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 206 KB πŸ‘ 2 views

Although the combination of cisplatin and etoposide has been used as standard therapy for small-cell lung cancer, it is difficult to demonstrate combination effects between cisplatin and etoposide in vitro. We therefore adopted a 3-dimensional (3-D) model to analyze the combination effects of antica